Biography

Deka Prismawan obtained his bachelor and apothecary degree from Airlangga University. After two years of working in a pharmaceutical company, he undertook a master study in Medical Pharmaceutical Sciences at the University of Groningen, the Netherlands. During his master’s program, he performed his first research project in the group of Prof. Alexander Dömling in Groningen Research Institute of Pharmacy, working on the multicomponent reaction-based synthesis of macrocycles targeting protein-protein interactions. His second research project focused on the development of human 15-lipoxygenase-1 inhibitors from the previously identified indolyl scaffold hit using combinatorial chemistry under the supervision of Prof. Frank J. Dekker and Prof. Anna K. H. Hirsch at Stratingh Institute for Chemistry. He completed his master’s degree in 2018, and he currently works in the Faculty of Medicine and Health Sciences in Atma Jaya Catholic University of Indonesia. His research interests are synthetic organic chemistry, medicinal chemistry, and computer-aided drug design.

Education

Mr. Deka Prismawan completed his Bachelor of Pharmacy degree at Airlangga University, Indonesia, in 2013, followed by obtaining his Pharmacist degree from the same university in 2014. He then pursued his Master’s degree at the University of Groningen, Netherlands, and earned his M.Sc. in 2018.

Expertise

Mr. Deka's expertise lies in the field of Organic Chemistry, with a particular focus on Drug Synthesis and Molecular Drug Design. He has a deep understanding of the chemical processes involved in drug development as well as the application of molecular design in creating new pharmaceutical compounds.

Teaching

As an instructor, Deka teaches various courses in the Bachelor of Pharmacy program, including Basic Chemistry, Organic Chemistry, Biochemistry, Analytical Chemistry I and II, as well as Medicinal Chemistry. In addition, he also teaches practical courses such as Drug, Food, and Cosmetic Analysis, Industrial Pharmacy, Forensic Pharmacy, and Drug Innovation, aimed at preparing students for the professional world of pharmacy.

Recent Publications

Deka Prismawan, S.Farm, Apt., M.Sc. is a researcher in the field of pharmacy focused on the development of bioactive compounds and drug formulation. With expertise in molecular modeling and compound synthesis, Deka has produced several significant publications aimed at addressing various health issues.

In the publication "Molecular Modeling, Synthesis, and QSAR of 5-O-Acylpinostrobin Derivatives as Promising Analgesic Agent," Deka conducts molecular modeling and synthesis of 5-O-acylpinostrobin derivatives that show promise as analgesic agents. This research explores the potential of these compounds in pain treatment, providing a strong foundation for new drug development.

Furthermore, in the publication "Function of Selected Natural Antidiabetic Compounds with Potential Against Cancer via Modulation of the PI3K/AKT/mTOR Cascade," Deka investigates the role of natural antidiabetic compounds with potential anticancer properties. This study reveals how these compounds can modulate the PI3K/AKT/mTOR pathway, which is crucial in cancer development, offering safer treatment alternatives.

Deka has also contributed to the field of formulation with his publication "Optimization of Sunscreen Cream Formulation Containing Ethanolic Extract of Avocado Leaves (Persea americana Mill.) or Mangosteen Rind (Garcinia mangostana L.) Combined with Octyl Methoxycinnamate." This research explores the optimization of sunscreen cream formulation containing ethanolic extracts of avocado leaves and mangosteen rind, demonstrating the potential of natural ingredients in effective and safe skincare products.

Additionally, Deka is involved in research published in Helvetica Chimica Acta, titled "Replacement of an Indole Scaffold Targeting Human 15-Lipoxygenase-1 Using Combinatorial Chemistry." This study explores the use of combinatorial chemistry to replace the indole scaffold in targeting human 15-lipoxygenase-1, an enzyme associated with inflammation and chronic diseases.

With his dedication to the field of pharmacy and research, Deka Prismawan, S.Farm, Apt., M.Sc. continues to make significant contributions to innovative drug development and formulation, positively impacting public health.